Atlas Trials

Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD

Clinical trial NCT07418177 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07418177
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AMD - Age-Related Macular Degeneration
Start date
2026-02-10
Primary completion
2028-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.